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Abstract The contents of free phenolic acids and cinnamic acid were determined using an
HPLC method in methanolic extracts from biomass of Schisandra chinensis (Turcz.) Baill.
(Chinese magnolia vine) at different stages of organogenesis, cultured in vitro on a few variants
of Murashige and Skoog (MS) medium, containing different concentrations of plant growth
regulators 6-benzylaminopurine (BAP) and 1-naphthaleneacetic acid (NAA) (from 0.1 to
3.0 mg/l) and in extracts from overground parts of plants growing in vivo. Six of 12 analysed
compounds were detected in all extracts: chlorogenic, p-coumaric, p-hydroxybenzoic, proto-
catechuic, salicylic and syringic acids. Total contents of the examined metabolites in biomass of
shoot-differentiating callus culture cultivated on six MS medium variants were dependent on
concentrations of growth regulators in the media and ranged from 14.90 to 60.05 mg/100 g d.w.
Total contents of the compounds in biomass extracts from undifferentiating callus culture
maintained only on two of six MS medium variants were higher and amounted to 74.54 and
78.24 mg/100 g d.w. Maximum total contents of phenolic acids in both types of in vitro cultures
were greater than in fruits (55.73 mg/100 g d.w.) and leaves (4.55 mg/100 g d.w.) of plants
gowning in vivo. Chlorogenic acid and salicylic acid were the main compounds identified in
biomass extracts of shoot-differentiating callus cultures (max 22.60 and 21.17 mg/100 g d.w.,
respectively), while chlorogenic acid (max 38.43 mg/100 g d.w.) and protocatechuic acid (max
20.95 mg/100 g d.w.) prevailed in the extracts from undifferentiating callus cultures. Other
compounds dominated in fruits, namely p-coumaric acid (23.36mg/100 g d.w.) and syringic acid
(14.96 mg/100 g d.w.). This is the first report on biochemical potential of cells from S. chinensis
in vitro cultures to produce the biologically active phenolic acids. These are the first results on the
analysis of this group of metabolites in overground parts of plants growing in vivo, too.
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Schisandra chinensis (Turcz.) Baill (Chinese magnolia vine) is an East Asian species which
currently is very popular in Europe as an adaptogenic plant [1]. We can find the monography of
Schisandrae chinensis fructus in the newest edition of European Pharmacopoeia 7th and in the
National Pharmacopoeias of European countries e.g. in Polish Pharmacopoeia 9th [2, 3]. This
species has long been used in traditional Chinese medicine [4]. It was also much earlier known
as a medicinal plant in North America than in Europe [5–7]. This plant species shows valuable
biological activities. Apart from its adaptogenic properties, it is known as a hepatoprotectant, an
antioxidant, and an anticancer drug. These properties have been attributed mostly to lignans,
dibenzocyclooctadiene derivatives, which were identified in fruits, shoots, and leaves [5, 6, 8].
Other groups of active substances of the fruits were demonstrated to belong to organic acids
(citric, malic, tartaric and fumaric acids), sugars, phytosterols (e.g. stigmasterol), tannins,
volatile oil compounds (monoterpenes, sesquiterpenes), vitamins (e.g. C and E), and elements
Cu, Mg, Ni and Zn [1, 5, 6]. There was not any information about the occurrence of phenolic
acids in this plant species and other species of the Schisandra genus [8].
In vitro cultures of S. chinensis maintained in our laboratory have a potential to accumulate
some lignans. Our studies analysing the contents of two main compounds of this group—
schisandrol A and schisandrol B—revealed that biomass from shoot-differentiating callus culture
could be a potential biotechnological source of these metabolites [9]. Maximum contents of both
compounds obtained from in vitro cultures (about 70 and 86 mg/100 g d.w., respectively) were
greater than in the studied leaves of the plants growing under natural conditions.
Lignans present in the plant species under study possess a unique structure, and their
biogenesis has not been elucidated in detail, yet, though its initial steps are known to belong
to the shikimic acid pathway, involved also in biogenesis of phenolic acids. These facts prompted
us to undertake analysis of this group of compounds both in biomass cultured in vitro and in
plants growing in vivo. The exceptional value of biological activity of this group of metabolites
strengthened our decision of their investigation. Phenolic acids, either cinnamic or benzoic acid
derivatives and depsides, like chlorogenic, and rosmarinic acids possess, e.g. anti-inflammatory,
cholagogic, spasmolytic, hypolipemic, anti-aggregatory and immunostimulating actions [10–
14]. Many new reports have also revealed anticancer, antiradical and antioxidant properties of
some compounds belonging to this group, like protocatechuic acid and caffeic acid and depsides,
e.g. chlorogenic acid [15–18]. Biotechnological studies of S. chinensis carried out in other
scientific centres focused on possibility to use enzymatic potential of the cells cultured in vitro
for biotransformation of hydroquinone into phenolic glycosides. Few papers dealt also with
micropropagation of this plant species, mainly by somatic embryogenesis. One report addressed
the problem of validation of lignans assays in material from in vitro cultures [19–23].
The present study aimed to investigate the accumulation of free phenolic acids and cinnamic
acid in biomass from in vitro cultures at different stages of differentiation cultivated on several
variants of Murashige and Skoog (MS) medium [24] containing varying amounts of plant
growth regulators: 6-benzylaminopurine (BAP; cytokinin) and 1-naphthaleneacetic acid (NAA;
auxin) ranging from 0.1 to 3.0 mg/l of themedium and to compare biosynthetic capacities of the
cells from in vitro cultures with cells of plants growing in vivo. Moreover, the studies aimed to
demonstrate the utility of in vitro cultures of S. chinensis as a potential biotechnological source
of the biologically active phenolic acids.
Twelve compounds were determined by an HPLC method in methanolic extracts from
biomass cultured in vitro and in the extracts from overground parts of plants growing under
natural conditions (fruits, leaves). In vitro cultures of S. chinensis have not been studied so
far in terms of the biochemical potential for production of free phenolic acids. Until now the
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native plant has not been studied for the contents of these metabolites, too. We found only
interesting information, about the high amounts of cinnamic acid—precursor of one group of
phenolic acids, in leaves of these plant species [25].
Materials and Methods
Establishment of In Vitro Cultures
The in vitro cultures were established from leaf buds of S. chinensis (Turcz.) Baill. (Schisan-
draceae) from the Rogów Arboretum—Warsaw University of Life Sciences, Forest Experimen-
tal Station in Rogów (Poland); for details, see Szopa and Ekiert [9]. After 4 weeks we obtained
two different cultures: shoot-differentiating callus culture and undifferentiating callus culture.
Experimental In Vitro Culture
The shoot-differentiating callus culture was maintained on six solid MS [24] medium variants
differing in concentrations of plant growth regulators, BAP and NAA (in milligrams per litre):
0.1 and 2.0, 0.5 and 2.0, 2.0 and 0.5, 2.0 and 1.0, 2.0 and 2.0, and 3.0 and 1.0. The callus culture
was cultivated on two solid MSmedium variants, containing BAP and NAA (in milligrams per
litre): 2.0 and 2.0, and 3.0 and 1.0. Both types of cultures were grown under constant artificial
light (4 W/m2, LF-40W lamp, daylight, Piła) at 25±2 °C for 4 weeks (three series).
Plant Material
Plant material harvested in Poland in 2010, analysed for comparison, comprised fruits and
leaves of the plants growing under natural conditions (Rogów Arboretum—Warsaw University
of Life Sciences, Forest Experimental Station in Rogów, Poland).
Extraction and HPLC Analysis
The dried biomass from both types of in vitro cultures collected after 4-week growth cycles
(three series) and plant material—fruits and leaves (from 0.2 to 0.5 g)—were extracted twice
with boiling methanol for 3 h. In the methanolic extracts, chromatographic quantification of 11
phenolic acids and cinnamic acid was performedwith the HPLCmethod according to Tian et al.
[26]. Separation was performed using an analytical column Kinetex™ 18C (150×4.6 mm,
2.6 μm) at 25 °C. The mobile phase consisted of 0.1 % trifluoroacetic acid (A) and acetonitrile
(B); a flow rate was set on 1.0 ml/min (gradient programme), injection volume 5 μl. Detection
wavelength was set at 254 nm. Quantification was made by comparison with standards: caffeic,
chlorogenic, cinnamic, protocatechuic, rosmarinic, salicylic, sinapic and syringic acids (Sigma),
and p-coumaric, ferulic, p-hydroxybenzoic, and vanillic acids (Fluka).
Results
Shoot-Differentiating Callus Culture
Dry biomass of shoot-differentiating callus culture increased 2.1–6.1-fold during 4-week
growth cycles on the tested six variants of MS medium. High over fivefold biomass
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increments were observed on the medium variants containing cytokinin (BAP) and auxin
(NAA) at concentrations of 2 and 2, 2 and 1, and 3 and 1 mg/l of the medium.
Among 12 compounds under study, six phenolic acids were identified in the extracts:
chlorogenic, p-coumaric, p-hydroxybenzoic, protocatechuic, salicylic and syringic acids.
None of the extracts under analysis contained caffeic, cinnamic, ferulic, rosmarinic, sinapic
and vanillic acids (Fig. 1).
Total content of phenolic acids was dependent on MS medium variant and ranged from
14.90 to 60.05 mg/100 g d.w. Three medium variants containing 3 mg/l BAP and 1 mg/l NAA,
0.5 mg/l BAP and 2 mg/l NAA, and 2 mg/l BAP and 2 mg/l NAA were demonstrated to be
beneficial for accumulation of the studied metabolites (total contents reached 60.05, 58.25 and
47.98 mg/100 g d.w., respectively; Table 1).
The contents of individual metabolites were very diverse and ranged from 0.1 to
22.60 mg/100 g d.w. Their concentrations changed from 4.03- to 126.30-fold depending
on MS medium variant (Fig. 1).
Maximum contents of protocatechuic acid and syringic acid amounted to about
7.00mg/100 g d.w.Maximum amounts of p-hydroxybenzoic acidwere almost two times higher
reaching about 13.00 mg/100 g d.w. The accumulation of these three metabolites was enhanced
on the MS medium variant containing 3 mg/l BAP and 1 mg/l NAA. Two compounds,
chlorogenic acid and salicylic acid, were accumulated at higher amounts (max about
22.00 mg/100 g d.w.; Table 2). The greatest content of chlorogenic acid was observed in
biomass cultured on the MS medium variant supplemented with 2 mg/l BAP and 2 mg/l NAA.
It is worth emphasizing that high amounts of salicylic acid (over 16.00 mg/100 g d.w.) were
accumulated on three MS medium variants (max content on the medium containing 0.5 mg/
l BAP and 2 mg/l NAA).
Undifferentiating Callus Culture
Undifferentiating callus culture was maintained on two variants of MS medium containing























Fig. 1 Contents (in milligrams/100 g d.w.) of phenolic acids in biomass extracts from S. chinensis shoot-
differentiating callus culture. The values are the means of three experiments ± SE
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because the highest biomass increments in shoot-differentiating callus cultures of S. chinen-
sis were observed at these concentrations of plant growth regulators.
Biomass increments in undifferentiating callus cultures maintained on the above-
mentioned two variants of MS medium were of the same order of magnitude and
amounted to 7.4- and 7.6-fold, respectively. The extracts under analysis contained also
six metabolites of 12 compounds determined chlorogenic, p-coumaric, p-hydroxybenzoic,
protocatechuic, salicylic and syringic acids (Fig. 2). These phenolic acids were the same
as those detected in biomass extracts of shoot-differentiating callus cultures. Maximum
total contents of the mentioned six compounds were 78.24 and 74.54 mg/100 g d.w.,
respectively, and were 1.24- and 1.63-fold higher in comparison with the respective
values assayed in the extracts from biomass of shoot-differentiating callus cultures
(Table 1).
Chlorogenic acid and protocatechuic acid were the main metabolites (max contents 38.43
and 20.95 mg/100 g d.w., respectively; Fig. 2). The amounts of syringic acid (about
10.00 mg/100 g d.w.), p-coumaric acid (about 7.00 mg/100 g d.w.) and p-hydroxybenzoic
acid (about 4–4.5 mg/100 g d.w.) were smaller. Salicylic acid was accumulated at the lowest
amounts (below 0.7 mg/100 g d.w.; Table 2). The contents of individual metabolites
accumulated on two MS medium variants under study were generally comparable. Only in
the case of protocatechuic acid, the medium containing 2 mg/l BAP and 2 mg/l NAA was
more conducive to accumulation of this compound.
Table 1 Total contents (in milligrams/100 g d.w.) of free phenolic acids in biomass extracts from two types of
S. chinensis in vitro cultures cultured on variants of MS medium, containing different concentrations of plant
growth regulators
Type of culture MS medium variants [BAP (mg/l):NAA (mg/l)]
0.1:2 0.5:2 2:0.5 2:1 2:2 3:1
Shoot-differentiating callus culture 14.90 58.25 38.65 24.34 47.98 60.05
Undifferentiating callus culture – – – – 78.24 74.54
Undifferentiating callus culture was maintained only on two variants of MS medium (see Materials and
methods)
Table 2 Contents (in milligrams/100 g d.w.) of free phenolic acids in fruits and leaves of Schisandra
chinensis growing in vivo and their maximal contents in biomass from in vitro cultures




Chlorogenic acid 1.98 1.37 22.60 38.43
p-Coumaric acid 23.36 1.27 15.39 7.28
p-Hydroxybenzoic acid 2.60 0.20 12.66 4.43
Protocatechuic acid 5.81 0.33 7.22 20.95
Salicylic acid 7.01 0.92 21.17 0.67
Syringic acid 14.96 0.46 6.92 9.51
Total content 55.73 4.55 60.05 78.24
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Discussion
Concentrations of growth regulators in the MS [24] medium variants had a significant effect
on the accumulation of free phenolic acids in shoot-differentiating callus cultures of S.
chinensis. Depending on the MS medium variant, total contents of the compounds under
study ranged from 14.90 to 60.05 mg/100 g d.w. whereas contents of individual metabolites
changed from 4.03- to 126.30-fold.
The effect of composition and contents of growth regulators in culture media on the
accumulation of secondary metabolites in in vitro cultures is well known [27]. Our earlier
studies demonstrated their influence on the accumulation of different groups of metabolites:
linear furanocoumarins in callus cultures of two Apiaceae species—Ammi majus and
Pastinaca sativa [28, 29], free phenolic acids in shoot cultures of Ruta graveolens [30]
and recently lignans in shoot-differentiating callus cultures of S. chinensis [9].
In the present studies, maximum total contents of the compounds in shoot-
differentiating callus culture were obtained on MS media containing 3 mg/l BAP and
1 mg/l NAA, 0.5 mg/l BAP and 2 mg/l NAA, and 2 mg/l BAP and 2 mg/l NAA. The
first of the above-mentioned medium was also the best medium for lignans accumula-
tion in shoot-differentiating callus culture of S. chinensis [9].
Twomedia proposed now as beneficial for the production of phenolic acids in S. chinensis in
vitro cultures (3 mg/l BAP and 1 mg/l NAA, and 2 mg/l BAP and 2 mg/l NAA) were also
favourable for biomass growth (five- to sixfold increase in dry biomass). These variants of MS
medium can be proposed as universal, both “productive” and “growth-promoting” media.
Undifferentiating callus cultures were tested only on two MS medium variants containing
3 mg/l BAP and 1 mg/l NAA, and 2 mg/l BAP and 2 mg/l NAA. Total contents of phenolic
acids obtained on these media were 1.24- and 1.63-fold greater, respectively, than in the extracts
from shoot-differentiating callus cultures (Table 1). This result is surprising because usually a
higher degree of differentiation and organogenesis promotes the accumulation of secondary
metabolites [31]. Our earlier experiments on lignans accumulation in S. chinensis in vitro
cultures demonstrated many times higher contents of the lignans schisandrol A and B in shoot-
differentiating callus culture (about 70 and 86 mg/100 g d.w.) than in undifferentiating callus
culture (below 3 mg/100 g d.w.) [9]. As indicated by our studies, the accumulation of phenolic
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Fig. 2 Contents (in milligrams/100 g d.w.) of phenolic acids in biomass extracts from S. chinensis
undifferentiating callus culture. The values are the means of three experiments ± SE
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acids was not linked with the high degree of differentiation of S. chinensis biomass cultured in
vitro [32].
Chlorogenic acid was accumulated in shoot-differentiating callus culture at marked amounts,
and in undifferentiating callus culture, its contents were maximal (Table 2). This compound is a
product of initial steps of the shikimic acid pathway and is accumulated in many plant species
[32] and in in vitro cultures of some plant species (e.g. Arnica montana, Eleutherococcus
senticosus) [12]. Therefore, it is not surprising that this metabolite was accumulated at high
amounts in the in vitro cultures under study. Maximum contents of chlorogenic acid obtained
from the biomass cultured in vitro (reaching almost 20 and 40 mg/100 g d.w. in biomass at
different stages of organogenesis) are interesting from practical point of view. These results are
very promising especially considering exceptional biological activity of chlorogenic acid (e.g.
its anticancer, antiradical and immunostimulating properties) [15–18].
Extracts from overground parts of plants growing in vivo contained the same compounds
under study as biomass from in vitro cultures (Table 2). Extracts of fruits, which are a
pharmaceutical raw material, contained p-coumaric acid (23.36 mg/100 g d.w.) and syringic
acid (14.96 mg/100 g d.w.) as dominating metabolites. Chlorogenic acid content was very low
(below 2 mg/100 g d.w.). Leaves turned out to be a very poor source of phenolic acids (total
contents approximated 4.5 mg/100 g d.w.; Table 2). In leaves extracts, chlorogenic, p-coumaric
and salicylic acids were the main metabolites (1–1.4 mg/100 g d.w.). Two of these compounds
dominated in biomass extracts from in vitro cultures, too. Maximum total contents of phenolic
acids in biomass from in vitro cultures were 1.4 and 17.2 times higher than in overground parts
of plants—fruits and leaves, respectively (Table 2). Already at the present stage of research,
both types of S. chinensis in vitro cultures can be proposed as a rich potential biotechnological
source of biologically active phenolic acids and a good model for further studies on optimiza-
tion of production of these metabolites.
The results presented for the first time the biochemical potential of cells from S. chinensis
in vitro cultures to produce the phenolic acids. These are the first results on the analysis of
this group of metabolites in overground parts of plant growing in vivo, too.
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